Articles Tagged With:
-
Anti-Kickback Ruling Undercuts Some False Claims Act Cases
Courts are beginning to question how aggressive whistleblowers and government lawyers are concerning the use of the Anti-Kickback Statute as a predicate act for a False Claims Act violation.
-
Unique Ethical Concerns if Research Involves the Recently Deceased
Research on recently deceased humans is important to conduct, but there are many challenging ethical considerations.
-
Supreme Court Ruling Changes View of Wrongful Intent
A Supreme Court ruling is changing how a defendant’s knowledge of wrongdoing and intent to commit fraud is viewed in civil cases. The ruling has significant implications for healthcare cases in which the False Claims Act is involved.
-
Demand for Pediatric Ethics Consults Is Increasing
As a long-term member of the ethics committee at Akron Children’s Hospital, Julie M. Aultman, PhD, noticed a shift in the types of consultations in which ethicists were engaged. Consults involved a wide range of issues, from end-of-life care to organizational ethics. Overall, cases were becoming more complex.
-
Compliance Requirements Continue to Change, Need Close Attention
Healthcare compliance is a never-ending challenge, and the expectations change constantly. Staying abreast of new developments is essential. Some of the latest involve the False Claims Act, Medicare risk adjustments, and HIPAA enforcement.
-
Attorney-Client Privilege Is Vital, but Know Limitations
Attorney/client privilege can be vital in defending malpractice cases and managing other risk management issues. But sometimes, it is misunderstood by risk managers in healthcare, and missteps can have significant implications. Understanding attorney-client privilege is the first step to taking advantage of this important protection.
-
Resmetirom Tablets (Rezdiffra)
The U.S. Food and Drug Administration has approved the first drug and first-in-class for the treatment of metabolic dysfunction-associated steatohepatitis (formerly known as nonalcoholic steatohepatitis). Resmetirom is a selective thyroid hormone receptor-beta partial agonist and was granted an accelerated approval. It is distributed by Madrigal Pharmaceuticals, Inc. as Rezdiffra.
-
Quality, not Quantity: Plant-Based Carbs Might Result in Less Weight Gain
This long-term prospective study found that adults on low-carbohydrate diets rich in plant-based and whole grain sources of protein and fat experienced significantly less weight gain than those on other types of low-carbohydrate diets.
-
Food as Medicine? Follow the Evidence
In this randomized, controlled study of more than 400 individuals with uncontrolled type 2 diabetes and food insecurity, an intensive intervention offering healthy groceries and educational efforts failed to significantly affect glycemic control but resulted in heightened engagement with preventive healthcare services in the intervention group compared to the control.
-
Can Bariatric Surgery Control Blood Pressure Long-Term?
A randomized trial comparing bariatric surgery to medical therapy in hypertensive obese patients has shown that bariatric surgery effectively lowers blood pressure over five years of follow-up.